| Formulary Chapter 1: Gastro-intestinal system - Full Chapter
|
| 01.02 |
Antispasmodics and other drugs altering gut motility |
|
|
| 01.02 |
Other antispasmodics |
|
|
Dicycloverine
(tablets/oral soution)
 
|
Non Formulary
|
|
Glycopyrronium 320micrograms/ml (Sialanar®)
(oral solution)
|
Non Formulary
|
May be continued in existing patients.
1mg/5ml oral solution preferred for new patients.
|
Key |
|
|
|
|
Cytotoxic Drug
|
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Traffic Light Status Information
| Status |
Description |
|
Suitable for prescribing by all in both primary and secondary care. |
|
Specialist recommended but suitable for continuation in primary care. |
|
Specialist initiated but suitable for continuation in primary care. |
|
Specialist initiated and for continuation in primary care under a locally approved shared care guideline. |
|
Suitable for prescribing in specialist settings (secondary care) only. |
|
Secondary care medicines to be used under specialised commissioning arrangements only. |
|
For primary care, either via FP10 or supplied through specialist services. These products may be stocked by hospital
pharmacies only for supply to primary care units/wards or for continuing supplies for patients admitted on therapy. |
|
Not recommended for use. |
|
|
For severe sialorrhoea in children and adolescents with chronic neurological disorders.
unlicensed
